This Core is responsible for the collection of peripheral blood, serum, and bone marrow from patients with monoclonal gammopathy of undetermined significance, multiple myeloma, smoldering multiple myeloma, and primary systemic amyloidosis. All serum and urine electrophoretic patterns which are performed are personally scanned by one of the consultants working in the Special Protein Laboratory. Those with a suspicion of a monoclonal protein on the cellulose acetate strip are identified, and if the patient has not previously been recognized, immunoelectrophoresis or immunofixation is done. The patient's physician is notified of the result by telephone. All returning patients are identified so that other laboratory studies can be obtained. Serum, urine, peripheral blood, and bone marrow cells are collected and stored for further studies as well as a resource for other activities. The Cell Kinetics Laboratory will serve as a center for acquisition and distribution of cells for the Program Project. The central acquisition of cells assures that all laboratories (Projects II, III, and IV) receive an adequate number of cells for study. The Cell Bank is a centralized facility for the accession, distribution, and cryopreservation of cells from bone marrow and peripheral blood of patients with MGUS, multiple myeloma, primary amyloidosis, and related disorders.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA062242-04
Application #
6237453
Study Section
Project Start
1997-08-01
Project End
1999-03-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Lwin, S T; Fowler, J A; Drake, M T et al. (2017) A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo. Mol Cancer 16:49
Gonsalves, W I; Rajkumar, S V; Dispenzieri, A et al. (2017) Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression. Leukemia 31:130-135
Mullikin, Trey C; Rajkumar, S Vincent; Dispenzieri, Angela et al. (2016) Clinical characteristics and outcomes in biclonal gammopathies. Am J Hematol 91:473-5
Gonsalves, Wilson I; Timm, Michael M; Rajkumar, S Vincent et al. (2016) The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma. Leuk Res 44:32-9
Kaufman, Gregory P; Dispenzieri, Angela; Gertz, Morie A et al. (2015) Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis. Am J Hematol 90:181-6
Gonsalves, W I; Leung, N; Rajkumar, S V et al. (2015) Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma. Blood Cancer J 5:e296
Landgren, O; Graubard, B I; Katzmann, J A et al. (2014) Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey. Leukemia 28:1537-42
Kumar, S K; Dispenzieri, A; Lacy, M Q et al. (2014) Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 28:1122-8
Gonsalves, Wilson I; Rajkumar, S Vincent; Go, Ronald S et al. (2014) Trends in survival of patients with primary plasma cell leukemia: a population-based analysis. Blood 124:907-12
Wong, Tina W; Doyle, Alfred D; Lee, James J et al. (2014) Eosinophils regulate peripheral B cell numbers in both mice and humans. J Immunol 192:3548-58

Showing the most recent 10 out of 365 publications